Adelene Q Perkins insider trades: Infinity Pharmaceuticals (INFI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adelene reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | INFI | ↓ Sell10b5-1 | 410,196 | $0.07 | $29K | Direct | Sep 12, 2023 (0d) |
| Oct 1, 2018 | INFI | ↓ Sell10b5-1 | 5,000 | $2.82 | $14K | Direct | Oct 2, 2018 (1d) |
| Mar 5, 2018 | INFI | ↓ Sell10b5-1 | 5,000 | $2.78 | $14K | Direct | Mar 7, 2018 (2d) |
| Jun 25, 2015 | INFI | ↓ Sell10b5-1 | 5,000 | $10.93 | $55K | Direct | Jun 26, 2015 (1d) |
| May 27, 2015 | INFI | ↓ Sell10b5-1 | 10,000 | $12.81 | $128K | Direct | May 28, 2015 (1d) |
| May 14, 2015 | INFI | ↓ Sell10b5-1 | 10,000 | $12.18 | $122K | Direct | May 15, 2015 (1d) |
| Mar 16, 2015 | INFI | ↓ Sell10b5-1 | 20,000 | $16.00 | $320K | Direct | Mar 17, 2015 (1d) |
| Mar 5, 2015 | INFI | ↓ Sell10b5-1 | 25,000 | $16.50 | $413K | Direct | Mar 9, 2015 (4d) |
| Jan 29, 2015 | INFI | ↓ Sell10b5-1 | 20,000 | $14.83 | $297K | Direct | Feb 2, 2015 (4d) |
| Sep 13, 2013 | INFI | ↓ Sell | 45,000 | $20.72 | $932K | Direct | Sep 13, 2013 (0d) |
| Dec 16, 2010 | INFI | ↑ Buy | 25,000 | $6.10 | $153K | Direct | Dec 17, 2010 (1d) |
| Aug 25, 2010 | INFI | ↑ Buy | 50,000 | $4.90 | $245K | Direct | Aug 26, 2010 (1d) |
| Dec 17, 2008 | INFI | ↑ Buy | 9,200 | $7.90 | $73K | Direct | Dec 18, 2008 (1d) |
| Nov 25, 2008 | INFI | ↑ Buy | 22,041 | $6.16 | $136K | Direct | Nov 26, 2008 (1d) |
| Mar 17, 2008 | INFI | ↑ Buy | 776 | $5.91 | $5K | Direct | Mar 18, 2008 (1d) |
| Jun 15, 2007 | INFI | ↑ Buy | 10,000 | $10.64 | $106K | Direct | Jun 18, 2007 (3d) |
| May 11, 2007 | INFI | ↑ Buy | 6,446 | $10.86 | $70K | Direct | May 11, 2007 (0d) |
| May 7, 2007 | INFI | ↑ Buy | 15,148 | $11.03 | $167K | Direct | May 7, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Adelene Q Perkins's insider trades
Adelene Q Perkins is a director at Infinity Pharmaceuticals (INFI). Since May 7, 2007, Adelene has reported 8 open-market purchases worth $954K and 10 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
9 sales (60% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (32 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INFI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.